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Whole organ transplantation practices have text to exploit basic immunologic information in xe-
brought this form of surgical treatment to a high no transplantation and other initiatives, 
level of efficiency and success, contrary to the pes- This 2-way (bidirectional) paradigm has been un-
simistic predictions at the outset of most immunolo- der intense examination because it has mandated re-
gists. Historically, an allograft was envisioned as de- examination of transplantation immunology at every 
fenseless and vulnerable to immunologic attack in level. First, the 2-way paradigm established the long 
proportion to its histocompatibility disparity with sought linkage between the whole organ transplant 
that of the recipient. This dogma defined transplan- practices that were evolved empirically and the 
tation in terms of a unidirectional immune reaction neonatal acquired immunologic tolerance originally 
both for bone marrow and organs (a one-way para- described more than 40 years ago by Billingham, 
digm) (Fig. 1). Brent, and Medawar (7,8). The discoveries of spon-
The one-way paradigm was unchallenged for more taneous chimerism gave startling insight into what 
than 3 decades until in 1992, we discovered the pres- was actually being accomplished with whole organ 
ence of ubiquitous low level donor leukocyte chime- transplantation, allowing a revision of historic con-
rism in our human organ recipients as long as 30 text. 
years posttransplantation (1,2). We postulated from More importantly, these discoveries have illumi-
these findings (and subsequently obtained much nated the future (9). The mechanisms leading to 
confirmatory evidence [3-5]) that the interaction of chimerism and governing allograft acceptance also 
2 coexisting donor and recipient leukocyte popula- ultimately determine the outcome after xenotrans-
tions, each to the other, was the generic mechanism plantation. Although it will be difficult to first breech 
of successful tolerance after bone marrow transplan- the humoral barrier, manipulating the individual 
tation as well as the acceptance of organ allografts limbs of the 2-way reaction (host versus graft and 
(Fig. 2). graft versus host) is expected to be the key to 
The phenomenology of microchimerism has been the ultimate successful use of animal organs in hu-
widely verified in experimental models. The mutual mans. 
cancelling effect of the coexisting cell populations 
explains the blurring of a major histocompatibility 
complex (MHC) matching effect on the outcome of 
organ transplantation, the ability to transplant his to-
incompatible liver, intestine, and bone marrow to 
the noncytoablated recipient without causing graft-
versus-host disease (GVHD), and the ability to stop 
immunosuppression in many organ recipients (1,2,6). 
Most importantly, this concept provides a fresh con-
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FIG. 1. Shown is the one-way paradigm in which transplantation 
is conceived as involving a unidirectional immune reaction: host-
versus-graft (HVG) with whole organs and graft-versus-host 
(GVH) with bone marrow or other lymphopoietic transplants. 
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FIG. 2. Shown is the two-way paradigm in which transplantation 
is seen as a bidirectional and mutually cancelling immune reac-
tion that is predominantly HVG with whole organ grafts and pre-
dominantly GVH with bone marrow grafts. 
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